Skip to main content
Log in

Mixed neuroendocrine–non-neuroendocrine neoplasm with squamous cell carcinoma covered by tubulovillous adenoma in the rectum

  • Case Report
  • Published:
Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

A variety of histologies is often mixed in neuroendocrine carcinoma (NEC) called mixed neuroendocrine–non-neuroendocrine neoplasm (MiNEN). However, tumors consisting of both large-cell NEC and squamous cell carcinoma (SCC) are rare. NEC of the large intestine is aggressive; however, an ideal treatment strategy has not been established. In this study, we have reported a case of rectal MiNEN containing large-cell NEC and SCC that was covered by tubulovillous adenoma. A 73-year-old man was referred to our hospital for the treatment of an upper rectal tumor. The results of preoperative biopsy indicated tubulovillous adenoma, whereas computed tomography revealed multiple liver tumors and swollen lymph nodes around the rectum. Laparotomy was performed because of severe dyschezia caused by rectal stenosis. Hartmann’s operation was performed because of peritoneal metastases. Histopathological examination of the rectal tumor revealed MiNEN containing large-cell NEC, SCC, well-differentiated adenocarcinoma, and tubulovillous adenoma covering the surface of the tumor. The patient died 73 days after surgery due to liver metastases. It is important to consider NEC in the differential diagnosis and tissue sampling should be performed to ensure appropriate management when pathological findings and clinical diagnosis do not match. More research is required to determine the ideal treatment for these rare and aggressive tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Juturi JV, Francis B, Koontz PW, et al. Squamous-cell carcinoma of the colon responsive to combination chemotherapy: report of two cases and review of the literature. Dis Colon Rectum. 1999;42:102–9.

    Article  CAS  Google Scholar 

  2. Rindi G, Komminoth P, Scoazec JY, et al. Colorectal neuroendocrine neoplasms. In: World Health Organization (ed) WHO Classification of Tumours of the Digestive System. 5th edn. Geneva, pp. 188–191; 2019.

  3. Bernick PE, Klimstra DS, Shia J, et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum. 2004;47:163–9.

    Article  CAS  Google Scholar 

  4. Sato H, Koh PK, Bartolo DCC. Management of anal canal cancer. Dis Colon Rectum. 2005;48:1301–15.

    Article  Google Scholar 

  5. Shia J, Tang LH, Weiser MR, et al. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity? Am J Surg Pathol. 2008;32:719–31.

    Article  Google Scholar 

  6. Kudo S, Tamura S, Nakajima T, et al. Diagnosis of colorectal tumorous lesions by magnifying endoscopy. Gastrointest Endosc. 1996;44:8–14.

    Article  CAS  Google Scholar 

  7. Japan Society for Cancer of the Colon and Rectum. Japanese classification of colorectal carcinoma 2nd English edition. Kanehara & Co, Tokyo; 2009.

  8. Klimstra DS, Modlin IR, Coppola D, Lloyd RV, Suster S. The pathologic classification of neuroendocrine tumors a review of nomenclature, grading, and staging systems. Pancreas. 2010;39:707–12.

    Article  Google Scholar 

  9. Maggard MA, O’Connell JB, Ko CY. Updated population based review of carcinoid tumors. Ann Surg. 2004;240:117–22.

    Article  Google Scholar 

  10. Li Y, Yau A, Schaeffer D, et al. Colorectal glandular-neuroendocrine mixed tumor: pathologic spectrum and clinical implications. Am J Surg Pathol. 2011;35:413–25.

    Article  Google Scholar 

  11. Paniz Mondolfi AE, Slova D, Fan W, et al. Mixed adenoneuroendocrine carcinoma (MANEC) of the gallbladder: a possible stem cell tumor? Pathol Int. 2011;61:608–14.

    Article  Google Scholar 

  12. Ngo N, Edriss H, Figueroa JA, et al. Squamous cell carcinoma of the sigmoid colon presenting with severe hypercalcemia. Clin Colorectal Cancer. 2014;13:251–4.

    Article  Google Scholar 

  13. Kawasaki K, Kohta T, Matano M, et al. An organoid biobank of neuroendocrine neoplasms enables genotype-phenotype mapping. Cell. 2020;183:1420–35.

    Article  CAS  Google Scholar 

  14. Saclarides TJ, Szeluga D, Staren ED. Neuroendocrine cancers of the colon and rectum. Results of a ten-year experience. Dis Colon Rectum. 1994;37:635–42.

    Article  CAS  Google Scholar 

  15. Gaffey MJ, Mills SE, Lack EE. Neuroendocrine carcinoma of the colon and rectum. A clinicopathologic: ultrastructural, and immunohistochemical study of 24 cases. Am J Surg Pathol. 1990;14:1010–23.

    Article  CAS  Google Scholar 

  16. Milione M, Maisonneuve P, Spada F, et al. The clinicopathologic heterogeneity of grade 3 gastroenteropancreatic neuroendocrine neoplasms: morphological differentiation and proliferation identify different prognostic categories. Neuroendocrinology. 2017;104:85–93.

    Article  CAS  Google Scholar 

  17. Galizia G, Lieto E, Orditura M, et al. First-line chemotherapy vs bowel tumor resection plus chemotherapy for patients with unresectable synchronous colorectal hepatic metastases. Arch Surg. 2008;143:352–8.

    Article  Google Scholar 

  18. van Steenbergen LN, Elferink MA, Krijnen P, et al. Improved survival of colon cancer due to improved treatment and detection: a nationwide population-based study in The Netherlands 1989–2006. Ann Oncol. 2010;21:2206–12.

    Article  Google Scholar 

  19. Stillwell AP, Buettner PG, Ho YH. Meta-analysis of survival of patients with stage IV colorectal cancer managed with surgical resection versus chemotherapy alone. World J Surg. 2010;34:797–807.

    Article  CAS  Google Scholar 

  20. Network NCC. Clinical practice guidelines in oncology: neuroendocrine and adrenal tumors Version 1 2019. http://www.nccn.org; 2019.

  21. Strosberg JR, Coppola D, Klimstra DS, et al. North American Neuroendocrine Tumor Society (NANETS).The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas. Pancreas. 2010;39:799–800.

    Article  Google Scholar 

  22. Komatsubara T, Koinuma K, Miyakura Y, et al. Endocrine cell carcinomas of the colon and rectum: a clinicopathological evaluation. Clin J Gastroenterol. 2016;9:1–6.

    Article  Google Scholar 

Download references

Acknowledgements

The authors would like to thank MARUZEN-YUSHODO Co., Ltd. (https://kw.maruzen.co.jp/kousei-honyaku/) for the English language editing.

Funding

No financial support was received for the work described in this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Harunobu Sato.

Ethics declarations

Conflict of interest

Harunobu Sato, Miho Shiota, Makoto Urano, Tetsuya Tsukamoto, Katsuyuki Honda, Kunihiro Toyama and Ichiro Uyama declare that they have no conflict of interest.

Human Rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from the participant included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sato, H., Shiota, M., Urano, M. et al. Mixed neuroendocrine–non-neuroendocrine neoplasm with squamous cell carcinoma covered by tubulovillous adenoma in the rectum. Clin J Gastroenterol 14, 1136–1141 (2021). https://doi.org/10.1007/s12328-021-01420-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-021-01420-8

Keywords

Navigation